http://bit.ly/2uhKBiS Nathan Folwer, M.D, is an assistant professor in the Lymphoma/Myeloma department at MD Anderson.
His interest in immunomodulatory agents began during his hematology/oncology fellowship at Georgetown University Hospital, where he helped develop some of the first protocols to use lenalidomide in CLL.
Since joining the faculty at MD Anderson, the goal of his clinical research has been to further develop novel therapeutic regimens utilizing immunomodulatory agents to benefit patients with low grade non-Hodgkin's lymphoma.
He serves as the chairman of several phase I and investigator-initiated phase II trials for patients with non-Hodgkin's lymphoma, which includes leading the largest clinical study to use immunomodulatory drugs for untreated low grade lymphoma.
He has had the opportunity to develop collaborative relationships with basic scientists across multiple departments, and as a member of the phase I team he has experience developing cutting edge translational projects for patients with lymphoma. #endcancer
Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/RequestAppo...
Meet medical oncologist Nathan Fowler center for reproductive rights | |
| 19 Likes | 19 Dislikes |
| 1,824 views views | 46.7K followers |
| Film & Animation | Upload TimePublished on 3 Jul 2017 |
Không có nhận xét nào:
Đăng nhận xét